Genetic testing for non-ischemic heart muscle disease
Part of Genetic & congenital, Heart & circulation clinical trials.
This study offers genetic testing to adults with a type of heart muscle disease (non-ischemic cardiomyopathy or dilated cardiomyopathy) that is not caused by blocked arteries. The goal is to find genetic causes, which may guide treatment and family screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with non-ischemic cardiomyopathy or dilated cardiomyopathy (heart muscle disease not due to blocked arteries).
- Depending on where you live (BC or Alberta), you have additional features: in BC, this includes a family history, heart rhythm issues, or diagnosis under age 70; in Alberta, this includes a specific measure of heart pumping function (LVEF less than 50%) with heart enlargement.
- You have not already had genetic testing that found a cause for your heart condition.
- You agree to genetic testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
This study looks at whether certain antibodies (proteins in your blood) can help predict how dilated cardiomyopathy will progress. By testing your blood, researchers hope to learn more about your condition and find better ways to manage it.
This study follows people with a specific genetic change (in the BAG3 gene) that causes heart muscle weakness, to learn more about how the condition progresses over time. It does not test a new drug, but it helps researchers understand the disease better, which may lead to future treatments.
This study looks at how small blood vessels in the heart affect outcomes in people with dilated cardiomyopathy (an enlarged, weak heart). You may qualify if you have heart failure with a weak pump and no significant blockages in your main heart arteries.
This study is a registry for people with dilated cardiomyopathy (DCM)—a condition where the heart's main pumping chamber becomes enlarged and weak. It aims to learn more about DCM, especially in people from different ethnic backgrounds, by collecting health information over time.
This study aims to find and treat rare types of heart muscle disease early. If you have heart failure but no known heart disease, researchers will use MRI and other tests to see if a rare cause is behind your symptoms and then offer targeted treatment.
Hear when a new Nonischemic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.